Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014906 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea
A Phase 4 study of Rosacea, sponsored by Dermatology Specialists Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05014906 is a Phase 4 study of Rosacea that has completed, run by Dermatology Specialists Research. The registered enrollment target is 60 participants, below the 240-participant average among 23 other Rosacea trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05014906, a Phase 4 study of Rosacea, has completed, sponsored by Dermatology Specialists Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Rosacea is one of the most commonly occurring dermatoses treated by dermatologist today. Rosacea is an inflammatory condition of the skin presenting as flushing and or blushing along with redness, swelling, telangiectasia, and acne lesions. Minocycline has shown beneficial in the treatment of inflammatory acne lesions in patients with rosacea. This study is to evaluate the efficacy and tolerability of minocycline (Solodyn) alone versus minocycline (Solodyn) in combination with azelaic acid 15%(Finacea) in the treatment of rosacea.
Conditions Studied
Interventions
- DRUG Minocycline 45 MG
- DRUG Azelaic acid
Study Locations (1)
Kentucky
- Dermatology Specialists - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05014906
The ClinicalTrials.gov registry entry for NCT05014906 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 240-participant average among 23 other Rosacea trials with a reported enrollment target (75% lower). The listed sponsor is Dermatology Specialists Research, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rosacea appearing as the primary indexed condition, and to 2 interventions - of which Minocycline 45 MG is the first listed.
NCT05014906 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT05014906 about?
NCT05014906 is a clinical study titled "Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea". Rosacea is one of the most commonly occurring dermatoses treated by dermatologist today. Rosacea is an inflammatory condition of the skin presenting as flushing and or blushing along with redness, swelling, telangiectasia, and acne lesions. Minocycline has shown beneficial in the treatment of inflam...
What is the current status of trial NCT05014906?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2010-05. Estimated completion is 2011-09.
What conditions does trial NCT05014906 study?
This clinical trial studies the following conditions: Rosacea.
What interventions are being tested in trial NCT05014906?
The interventions under investigation include: Minocycline 45 MG (DRUG), Azelaic acid (DRUG).
Who is sponsoring clinical trial NCT05014906?
This trial is sponsored by Dermatology Specialists Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05014906 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ORCA - Oracea® for Rosacea: A Community-based Assessment
COMPLETED · Phase 4
-
Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea
RECRUITING · NA
-
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
RECRUITING · Phase 2
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Analysis of the Microbiome in Rosacea
ACTIVE NOT RECRUITING · Early Phase 1
-
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.